Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.0021 | 1 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.00047 | 1 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.00044 | 1 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.00032 | 1 |